by Joel Rothman | Aug 31, 2009 | NutriSupLaw
This is a tale of two types of weight-loss products and how the Food and Drug Administration had different responses to similar problems with them. The separate, but not equivalent treatment raises questions about how the FDA operates. On Aug. 24, the FDA issued a...
by Joel Rothman | Aug 10, 2009 | NutriSupLaw
Notice anything different? You should. To celebrate the start of our fifth year, we gave the blog a makeover. Or as they say on the Web, a redesign. We think the new look does a better job of displaying blog entries and organizing our growing lists of resources, links...
by Joel Rothman | Jul 28, 2009 | NutriSupLaw
Several hours after our post on increased media coverage of the potential danger of supplement use by high school athletes, the Food & Drug Administration held a press conference and issued a public health advisory on body-building products and steroids. The...
by Joel Rothman | May 27, 2009 | NutriSupLaw
In the days following the FDA warning on the dangers of taking Hydroxycut and the manufacturer’s recall, the reaction has been more sliced than divided. There were the oft-seen reactions: NaturalNews headlined its commentary, “FDA Floats Hydroxycut Scare...
